As explained by researchers, study data demonstrated the objectivity and reliability of these digital tools when assessing plaque accumulation and they should be used in conjunction with comprehensive clinical examination in order to ensure a holistic assessment of oral health.
In their work “Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review”, researchers analyzed 16 studies from 20 publications: most of the studies showed no difference in respiratory parameters. This indicates that electronic nicotine delivery systems substitution for smoking likely does not result in additional harm to respiratory health.
Two CoEHAR researchers will be part of this great event: The CoEHAR Director, Giovanni Li Volti, who is also PI of the replica project, will discuss the latest results of the Replica project and the IN silicon Science Pi, Dr. Renée O’Leary, will present her latest work.
Replica researchers performed a standard toxicology battery of three assays used for product assessment and regulatory applications.
The DiaSmokeFree Working Group send a letter to the American Diabetes Association (ADA) expressing concern and seeking correction of a couple of statements in the ADA guidelines regarding the use…
Today has been released the report “Lives Saved Report - Integrating harm reduction into tobacco control”, indicating that significant lives can be saved through the widespread adoption of THR and…
Professor Li Volti talked about the Replica project results with a presentation titled "The impact of cigarette smoke and reduced risk products aerosol on endothelial function: the REPLICA project"
An online survey, conducted on approximately 70,000 exclusive and non-exclusive American adult vapers, highlighted that the most utilized flavors to quit smoking are those of fruit, baked goods, and chocolate. These flavors are considered helpful in preventing and reducing the risk of relapses, but concerns about youth addiction are pushing government to enact strict state regulations
As requested by experts in the letter: "Our hope is that, in light of scientific evidence, the FCTC and the European Union conduct a careful, balanced, and transparent review of the available scientific evidence regarding non-combustible products, compared to conventional cigarettes, to provide indispensable information for making decisions in the interest of millions of smokers."
At 11.15 am, October 19, prof. Polosa will host remotely the panel Longer Term Outcomes of Cessation and Harm Reduction with a presentation on "Changes in Health Symptoms - Results and Analysis Methodologies".
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.